Prevention is the future of healthcare, and one fast-growing health-tech firm is developing an AI platform that could transform early detection of diseases like diabetes and Alzheimer’s. Healthcare remains a constant need—and health-tech is quickly becoming one of the highest-impact investment sectors of the 21st century.
Governments, insurers, and patients are demanding care that’s better, more affordable, and more accessible—and they’re turning to health-tech to deliver it.
Why pay attention now? Because this company is positioned right at the intersection of artificial intelligence and healthcare—two of the fastest-growing and most transformative global sectors. With a proprietary AI platform and a bold mission to improve early disease detection, this small-cap firm is a mission-driven innovator leading the charge in preventative medicine.
Through a joint venture, the company is developing Vision AI, an advanced diagnostic platform that can detect retinal diseases like diabetic retinopathy within seconds. Using a simple eye test and AI algorithms, Vision AI helps catch diabetes early—before serious complications like blindness occur.
This technology is scalable, fast, and potentially game-changing for millions affected by chronic diseases. Early detection remains one of healthcare’s biggest unmet needs—and this platform is aiming to meet it head-on.
Companies that achieve FDA clearance (510(k)) or CE marking for early disease detection tools often gain massive credibility—and the attention of major players like Google (Verily), Apple (HealthKit), and Medtronic.
This company is now gearing up for FDA clinical trials.
This message is a PAID ADVERTISEMENT for Avant Technologies Inc (OTCQB: AVAI) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between July 15, 2025 and July 21, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Avant Technologies Inc (OTCQB: AVAI) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Avant Technologies Inc (OTCQB: AVAI) on avanttechnologies.com website for additional information about the relationship between Interactive Offers and Avant Technologies Inc (OTCQB: AVAI).
Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe.
StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com
